Cheng, Shih-Lung;
Lin, Ching-Hsiung;
Chu, Kuo-An;
Lin, sheng-Hao;
Lin, Horng-Chyuan;
Ko, Hsin-kuo;
che, Yung-Che;
Chen, Chia-Hung;
Sheu, Chau-Chyun;
Huang, Wei-Chang;
Lin, Meng-Chih.
Chronic obstructive pulmonary disease (COPD) has significant contributions to morbidity and mortality world-wide. Early symptoms of COPD are not readily distinguishable, resulting in a low rate of diagnosis and intervention. Different guidelines and recommendatations for the diagnosis and treatment of CO...
Duijts, Liesbeth;
van Meel, Evelien R;
Moschino, Laura;
Baraldi, Eugenio;
Barnhoorn, Magda;
Bramer, Wichor M;
Bolton, Charlotte E;
Boyd, Jeanette;
Buchvald, Frederik;
del Cerro, Maria Jesus;
Colin, Andrew A;
Ersu, Refika;
Greenough, Anne;
Halvorsen, Thomas;
Gremmen, Christiaan;
Kamphuis, Juliette;
Kotecha, Sailesh;
Rooney-Otero, Kathleen;
Schulzke, Sven;
Wilson, Andrew;
Rigau, David;
Morgan, Rebecca L;
Tonia, Thomy;
Roehr, Charles C;
Pijnenburg, Marielle W.
This document provides recommendations for monitoring and treatment of children in whom bronchopulmonary dysplasia (BPD) has been established and were discharged from the hospital, or who were older than 36 weeks of postmenstrual age. The guideline was based on pre-defined Population, Intervention, Com...
Miravitlles, M;
Soler-Cataluña, J. J;
Calle, M;
Molina, J;
Almagro, P;
Quintano, J. A;
Trigueros, J. A;
Cosío, B. G;
Casanova, C;
Antonio Riesco, J;
Simonet, P;
Rigau, D;
Soriano, J. B;
Ancochea, J.
La enfermedad pulmonar obstructiva crónica (EPOC) presenta una gran heterogeneidad clínica, por lo que su tratamiento se debe individualizar según el nivel de riesgo y el fenotipo. La Guía española de la EPOC (GesEPOC) estableció por primera vez en 2012 unas pautas de tratamiento farmacológico bas...
Jouneau, S;
Dres, M;
Guerder, A;
Bele, N;
Bellocq, A;
Bernady, A;
Berne, G;
Bourdin, A;
Brinchault, G;
Burgel, P. R;
Carlier, N;
Chabot, F;
Chavaillon, J. M;
Cittee, J;
Claessens, Y. E;
Delclaux, B;
Deslée, G;
Ferré, A;
Gacouin, A;
Girault, C;
Ghasarossian, C;
Gouilly, P;
Gut-Gobert, C;
Gonzalez-Bermejo, J;
Jebrak, G;
Le Guillou, F;
Léveiller, G;
Lorenzo, A;
Mal, H;
Molinari, N;
Morel, H;
Morel, V;
Noel, F;
Pégliasco, H;
Perotin, J. M;
Piquet, J;
Pontier, S;
Rabbat, A;
Revest, M;
Reychler, G;
Stelianides, S;
Surpas, P;
Tattevin, P;
Roche, N.
Chronic obstructive pulmonary disease (COPD) is the chronic respiratory disease with the most important burden on public health in terms of morbidity, mortality and health costs. For patients, COPD is a major source of disability because of dyspnea, restriction in daily activities, exacerbation, risk of ...
